Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy

Findings initiate prospective clinical trial at the Kimmel Cancer Center at Jefferson

2012-07-27

(Press-News.org) PHILADELPHIA—Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson report in a retrospective study published in a recent online issue of Clinical Cancer Research.

Many breast cancer patients undergo neoadjuvant therapy to reduce the size or extent of the cancer before surgical intervention. Complete response of the tumor to such treatment signifies an improved overall prognosis. Today, no marker is applied to identify tumors which will respond to such treatment, and as a result, only a subset of patients exhibit benefit from it.

"We found that loss of RB was associated with better pathological response rates in breast cancer patients—at various stages and representing multiple molecular subtypes—who were administered neoadjuvant chemotherapy," said Agnieszka Witkiewicz, M.D., Associate Professor of Pathology, Anatomy and Cell Biology at Thomas Jefferson University.

Erik Knudsen, Ph.D, Professor of Cancer Biology and the Hilary Koprowski Chair in Cancer Biology, was excited that discoveries from his life-long research on the RB-pathway were making there way into the clinic.

"This represents a potential new biomarker that could be used to tailor treatment plans for women considering neoadjuvant therapy and is a testament to the importance of cancer research," he said.

For the study, researchers, including Gordon Schwartz, M.D., Director of the Jefferson Breast Care Center and Adam Ertel, Ph.D., Bioinformatics Specialist, Department of Cancer Biology, performed a combination of gene expression profiling to identify those with RB loss and direct histological analysis in over 1,000 breast cancer patients who had undergone neoadjuvant therapy. These patients represented distinct subtypes of breast cancer and were treated with multiple different therapeutic regimens.

RB loss was associated, the team found, with an improved response to all the neoadjuvant regimens investigated in the major subtypes of breast cancer.

"Together, these data indicate that the loss of RB, which occurs relatively frequently in locally advanced disease, could be a useful tool for defining patients that experience an improved response to neoadjuvant chemotherapy," said Dr. Witkiewicz. "Based on these findings, we have initiated a prospective clinical trial at Jefferson, evaluating the association of RB and another marker, PTEN, with the response to neoadjuvant chemotherapy."

### The clinical trial is open to patients who have a diagnosis of triple negative breast cancer and are eligible for neoadjuvant chemotherapy. (clinicaltrials.gov/ct2/show/NCT01514565).

ELSE PRESS RELEASES FROM THIS DATE:

Solving the mystery of how cigarette smoking weakens bones

2012-07-27

Almost 20 years after scientists first identified cigarette smoking as a risk factor for osteoporosis and bone fractures, a new study is shedding light on exactly how cigarette smoke weakens bones. The report, in ACS' Journal of Proteome Research, concludes that cigarette smoke makes people produce excessive amounts of two proteins that trigger a natural body process that breaks down bone. Gary Guishan Xiao and colleagues point out that previous studies suggested toxins in cigarette smoke weakened bones by affecting the activity of osteoblasts, cells which build new bone, ...

Alcohol could intensify the effects of some drugs in the body

2012-07-27

Scientists are reporting another reason — besides possible liver damage, stomach bleeding and other side effects — to avoid drinking alcohol while taking certain medicines. Their report in ACS' journal Molecular Pharmaceutics describes laboratory experiments in which alcohol made several medications up to three times more available to the body, effectively tripling the original dose. Christel Bergström and colleagues explain that beverage alcohol, or ethanol, can cause an increase in the amount of non-prescription and prescription drugs that are "available" to the body ...

A new genre of diagnostic tests for the era of personalized medicine

2012-07-27

A new genre of medical tests – which determine whether a medicine is right for a patient's genes – are paving the way for increased use of personalized medicine, according to the cover story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society. Celia Henry Arnaud, C&EN senior editor, points out that the U.S. Food and Drug Administration has approved several precedent-setting cancer drugs that provide a glimpse of the "personalized" medical care that awaits patients ...

The first robot that mimics the water striders' jumping abilities

2012-07-27

The first bio-inspired microrobot capable of not just walking on water like the water strider – but continuously jumping up and down like a real water strider – now is a reality. Scientists reported development of the agile microrobot, which could use its jumping ability to avoid obstacles on reconnaissance or other missions, in ACS Applied Materials & Interfaces. Qinmin Pan and colleagues explain that scientists have reported a number of advances toward tiny robots that can walk on water. Such robots could skim across lakes and other bodies of water to monitor water ...

Decoding the secrets of balance

2012-07-27

If you have ever looked over the edge of a cliff and felt dizzy, you understand the challenges faced by people who suffer from symptoms of vestibular dysfunction such as vertigo and dizziness. There are over 70 million of them in North America. For people with vestibular loss, performing basic daily living activities that we take for granted (e.g. dressing, eating, getting in and out of bed, getting around inside as well as outside the home) becomes difficult since even small head movements are accompanied by dizziness and the risk of falling. We've known for a while ...

Big horns trump smooth pickup lines every time

2012-07-27

EAST LANSING, Mich. — Elk and rhinoceros beetles aren't diabetic, but to grow big horns and attract mates it appears that the males are insulin-dependent. Ian Dworkin, Michigan State University zoologist, was part of a team that for the first time ever showed why horns – from elk to rhinoceros beetles – and other decorative, mate-attracting structures are sensitive to changes in nutrition. As reported in the current issue of Science, the key ingredient for this growth is insulin, Dworkin said. "Clearly elk antlers, peacock tail feathers and beetle horns are very different, ...

Rivers flowing into the sea offer vast potential as electricity source

2012-07-27

WASHINGTON, July 25, 2012 — The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a process that could pave the way for a new genre of electric power-generating stations. These stations could supply electricity for more than a half billion people by tapping just one-tenth of the global potential of a little-known energy source that exists where rivers flow into the ocean. Based on a report by Menachem Elimelech, Ph.D., and Ngai Yin Yip in the ACS journal Environmental Science & Technology, ...

New research confirms efficacy of transcranial magnetic stimulation for depression

2012-07-27

PROVIDENCE, R.I. – In one of the first studies to look at transcranial magnetic stimulation (TMS) in real-world clinical practice settings, researchers at Butler Hospital, along with colleagues across the U.S., confirmed that TMS is an effective treatment for patients with depression who are unable to find symptom relief through antidepressant medications. The study findings are published online in the June 11, 2012 edition of Depression and Anxiety in the Wiley Online Library. Previous analysis of the efficacy of TMS has been provided through more than 30 published ...

Photovoltaics from any semiconductor

2012-07-27

A technology that would enable low-cost, high efficiency solar cells to be made from virtually any semiconductor material has been developed by researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley. This technology opens the door to the use of plentiful, relatively inexpensive semiconductors, such as the promising metal oxides, sulfides and phosphides, that have been considered unsuitable for solar cells because it is so difficult to taylor their properties by chemical means. "It's ...

MRSA cases in academic hospitals double in 5 years: study

2012-07-27

CHICAGO (July 26, 2012) -- Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled at academic medical centers in the U.S. between 2003 and 2008, according to a report published in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. Researchers from the University of Chicago Medicine and the University HealthSystem Consortium (UHC) estimate hospitalizations increased from about 21 out of every 1,000 patients hospitalized in 2003 to about 42 out of every 1,000 in 2008, ...

Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: